株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

次世代シーケンシング (NGS) 市場: 世界の業界動向・シェア・規模・成長・機会・予測 (2020-2025年)

Next-generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

発行 IMARC Services Private Limited 商品コード 945208
出版日 ページ情報 英文 104 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
次世代シーケンシング (NGS) 市場: 世界の業界動向・シェア・規模・成長・機会・予測 (2020-2025年) Next-generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日: 2020年06月18日 ページ情報: 英文 104 Pages
概要

世界の次世代シーケンシング (NGS) 市場は、力強い成長を示しています。癌のような慢性内科疾患の有病率の上昇は、医学分野における様々な技術的進歩とともに、市場の成長を牽引する主要な要因の1ひとつとなっています。癌診断における液体生検の普及により、NGS技術の利用が大幅に増加しています。さらに、さまざまな疾患の発症を予測するためのゲノムマッピングプログラムの採用の増加も、市場の成長を後押ししています。加えて、さまざまな技術的進歩とクラウドコンピューティングシステムとの統合により、データ管理が改善され、市場の成長にプラスの影響を与えています。 NGSシステムのコストの低下、シーケンス化学、分子生物学、技術工学の分野における広範な調査開発(R&D)活動といったその他の要因も、市場をさらに押し上げると予測されています。IMARC Group は、2020年から2025年の間に市場が約17%のCAGRを記録すると予測しています。

当レポートでは、世界の次世代シーケンシング (NGS) 市場について調査し、市場の概要、各セグメントおよび地域別による市場規模の予測、主要企業のプロファイル、競合情勢の分析など、体系的な情報を提供しています。

第1章 イントロダクション

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の次世代シーケンシング (NGS) 市場

  • 市場概要
  • 市場パフォーマンス

第6章 市場内訳:タイプ別

  • 全ゲノムシーケンシング
  • ターゲットリシーケンシング
  • 全エクソームシーケンシング
  • RNAシーケンシング
  • クロマチン免疫沈降(ChIP)シーケンシング
  • De novoシーケンシング
  • メチル化シーケンシング
  • その他

第7章 市場内訳:製品タイプ別

  • 装置
  • 試薬・消耗品
  • ソフトウェア・サービス

第8章 市場内訳:技術別

  • 塩基合成法 (SBS)
  • イオン半導体シーケンシング
  • 単一分子リアルタイムシーケンシング
  • ナノポアシーケンシング
  • その他

第9章 市場内訳:アプリケーション別

  • 創薬・個別化医療
  • 遺伝子スクリーニング
  • 診断
  • 農業および動物研究
  • その他

第10章 市場内訳:エンドユーザー別

  • 学術機関・研究センター
  • 病院・診療所
  • 医薬品・バイオテクノロジー企業
  • その他

第11章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 市場内訳:国別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格指標

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • Genomics
    • BGI Group
    • Eurofins Scientific
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Genewiz
    • Macrogen Inc.
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen N.V.
    • Genapsys Inc.
図表

List of Figures

  • Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
  • Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2019
  • Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2019
  • Figure 3: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2019
  • Figure 4: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2019
  • Figure 5: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2019
  • Figure 6: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Other Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Other Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: North America: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: North America: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: United States: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: United States: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Canada: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Canada: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: Asia Pacific: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: Asia Pacific: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: China: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: China: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: Japan: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: Japan: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: India: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: India: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: South Korea: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: South Korea: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Australia: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Australia: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Indonesia: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Indonesia: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Others: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Others: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Europe: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Europe: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: Germany: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: Germany: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: France: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: France: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: United Kingdom: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: United Kingdom: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: Italy: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Italy: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Spain: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Spain: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Russia: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Russia: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Others: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Others: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Latin America: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Latin America: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Brazil: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Brazil: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Mexico: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Mexico: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Others: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Others: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Middle East and Africa: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: Middle East and Africa: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: Global: Next-Generation Sequencing Industry: SWOT Analysis
  • Figure 79: Global: Next-Generation Sequencing Industry: Value Chain Analysis
  • Figure 80: Global: Next-Generation Sequencing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
  • Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million US$), 2020-2025
  • Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 8: Global: Next-Generation Sequencing Market Structure
  • Table 9: Global: Next-Generation Sequencing Market: Key Players
目次
Product Code: SR1019J9_Report

The global next-generation sequencing (NGS) market is currently witnessing robust growth. Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the market further. Looking forward, IMARC Group expects the market to register a CAGR of around 17% during 2020-2025.

Breakup by Sequencing Type:

  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Others

Breakup by Product Type:

  • Instruments
  • Reagents and Consumables
  • Software and Services

Breakup by Technology:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others

Breakup by Application:

  • Drug Discovery and Personalized Medicine
  • Genetic Screening
  • Diagnostics
  • Agriculture and Animal Research
  • Others

Breakup by End-User:

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in This Report:

  • How has the global next-generation sequencing market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the sequencing type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global next-generation sequencing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Sequencing Type

  • 6.1 Whole Genome Sequencing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Targeted Resequencing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Whole Exome Sequencing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 RNA Sequencing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 CHIP Sequencing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 De Novo Sequencing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Methyl Sequencing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents and Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software and Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing by Synthesis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ion Semiconductor Sequencing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Single-Molecule Real-Time Sequencing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nanopore Sequencing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Drug Discovery and Personalized Medicine
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Genetic Screening
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Agriculture and Animal Research
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Academic Institutes & Research Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals & Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical & Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 10x Genomics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 BGI Group
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Eurofins Scientific
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 F. Hoffmann-La Roche AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Genewiz
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Macrogen Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Oxford Nanopore Technologies
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Pacific Biosciences
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Perkinelmer Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis
    • 16.3.14 Qiagen N.V.
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio
      • 16.3.14.3 Financials
      • 16.3.14.4 SWOT Analysis
    • 16.3.15 Genapsys Inc.
      • 16.3.15.1 Company Overview
      • 16.3.15.2 Product Portfolio